معرفی
Dr. Benjamin Kimble is a Postdoctoral Research Associate at The Sydney School of Veterinary Science (SSVS), University of Sydney. His work focuses on laboratory-based pharmacokinetics, utilizing high-performance liquid chromatography and mass spectrometry. He specializes in bioanalytical development, in-vitro metabolism, and pharmacokinetic analysis, with particular emphasis on the tryptophan pathway in relation to diseases such as feline infectious peritonitis.
Dr. Kimble holds a BHSc, MHerbMed, MPhil, and PhD. His educational background spans health sciences, herbal medicine, and research methodology, providing him with a strong foundation for his current work in veterinary pharmacology and metabolomics.
Dr. Kimble's research primarily focuses on understanding how the tryptophan pathway responds in immune regulation related to diseases, investigating its potential as a diagnostic or prognostic marker, and developing advanced bioanalytical methods. His work bridges veterinary medicine, pharmacology, and metabolomics, with special attention to feline infectious peritonitis and koala medicine. He has made significant contributions to understanding drug metabolism in various animal species including cats, koalas, and other wildlife.
Analysis of Dr. Kimble's recent publications reveals a strong focus on pharmacokinetics across diverse animal species. His work spans veterinary pharmacology, metabolomics, and bioanalytical chemistry, with particular emphasis on feline infectious peritonitis treatment and koala medicine. Key trends include developing analytical methods for drug quantification, studying drug metabolism in wildlife species, and exploring novel therapeutic approaches for challenging veterinary conditions.
Dr. Kimble has secured competitive research funding for his work:
- 2024: "Investigation of tryptophan and kynurenines as predictive markers to monitor response to antiviral treatment in cats with feline infectious peritonitis (FIP)" funded by EveryCAT Health Foundation
- 2020: "Mefloquine for the treatment of feline infectious peritonitis FIP. Does a cats sex affect the rate of mefloquine metabolism" funded by Australian Companion Animal Health Foundation
- 2020: "Determining the clinical efficacy of mefloquine for treatment of naturally occurring feline infectious peritonitis stage 1" supported by Winn Feline Foundation (USA)
While specific lab affiliations aren't detailed in the provided information, Dr. Kimble's research appears to be conducted within the Sydney School of Veterinary Science, collaborating extensively with veterinary clinicians and researchers. His work involves sophisticated laboratory techniques including high-performance liquid chromatography and mass spectrometry, suggesting he works within specialized analytical and pharmacology laboratories at the University of Sydney.
